LANXESS Aktiengesellschaft, a specialty chemicals company, (LXS) Fair Value & Analysis
Basic Materials · DE · Market cap €1.4B
Fair value as of: Jun 25, 2026
Analysis
LANXESS Aktiengesellschaft, a specialty chemicals company, (LXS) currently trades at €16.56, while our model-based Fair Value estimate is €33.08 — implying the stock looks roughly 99.8% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the agrochemicals, pharmaceuticals, and specialty chemicals industries. It also offers additives, lubricants, flame retardants, plasticizers, and bromine derivatives for various rubber, plastic and paint, electrical/electronics, and construction industries. In addition, the company provides basic and fine chemicals, organometallics, and inorganic pigments for the coloring of construction materials, as well as paints and coatings. It serves the energ…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is LANXESS Aktiengesellschaft, a specialty chemicals company, (LXS) undervalued?
What is the fair value of LXS?
What is the quality score of LXS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.